Skip to main content
Top
Published in: Clinical and Experimental Nephrology 4/2010

01-08-2010 | Case Report

A girl with Peters plus syndrome associated with myelomeningocele and chronic renal failure

Authors: Osamu Motoyama, Hiroko Arai, Ryoko Harada, Kei Hasegawa, Kikuo Iitaka

Published in: Clinical and Experimental Nephrology | Issue 4/2010

Login to get access

Abstract

A girl was born with sclerocornea of the right eye, corneal staphyloma of the left eye and lumbar myelomeningocele. The myelomeningocele was repaired soon after birth. The corneal staphyloma was perforated during infancy. She received keratoplasty and achieved light perception. Her right kidney revealed multicystic dysplasia and was non-functioning at birth. She had neurogenic bladder, and her renal function deteriorated gradually. Peters plus syndrome was diagnosed based on anterior ocular segment anomalies, short stature, developmental delay and characteristic face. Anterior ocular segment anomalies are rare findings, but seem to be occasionally associated with spina bifida and renal anomalies. Myelomeningocele and chronic renal failure in patients with Peters plus syndrome have not been reported to our knowledge.
Literature
1.
go back to reference Laibson PR, Rapuano CJ. Diseases of the cornea. In: Nelson LB, editor. Harley’s pediatric ophthalmology. 4th ed. Philadelphia: WB Saunders; 1998. p. 215–57. Laibson PR, Rapuano CJ. Diseases of the cornea. In: Nelson LB, editor. Harley’s pediatric ophthalmology. 4th ed. Philadelphia: WB Saunders; 1998. p. 215–57.
3.
go back to reference Elder JS. Obstruction of the urinary tract. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics 18th ed. Philadelphia: Saunders Elsevier; 2007. p. 2234–43. Elder JS. Obstruction of the urinary tract. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics 18th ed. Philadelphia: Saunders Elsevier; 2007. p. 2234–43.
4.
go back to reference Suwa S, Tachibana K, Maesaka H, Tanaka H, Yokoya S. Longitudinal standards for height and height velocity for Japanese children from birth to maturity. Clin Pediatr Endocrinol. 1992;1:5–13. Suwa S, Tachibana K, Maesaka H, Tanaka H, Yokoya S. Longitudinal standards for height and height velocity for Japanese children from birth to maturity. Clin Pediatr Endocrinol. 1992;1:5–13.
5.
go back to reference Reis LM, Tyler RC, Abdul-Rahman O, Trapane P, Wallerstein R, Broome D, et al. Mutation analysis of B3GALTL in Peters plus syndrome. Am J Med Genet Part A. 2008;146A:2603–10.CrossRefPubMed Reis LM, Tyler RC, Abdul-Rahman O, Trapane P, Wallerstein R, Broome D, et al. Mutation analysis of B3GALTL in Peters plus syndrome. Am J Med Genet Part A. 2008;146A:2603–10.CrossRefPubMed
6.
go back to reference Elliott JH, Feman SS, O’Day DM, Garber M. Hereditary sclerocornea. Arch Ophthalmol. 1985;103:676–9.PubMed Elliott JH, Feman SS, O’Day DM, Garber M. Hereditary sclerocornea. Arch Ophthalmol. 1985;103:676–9.PubMed
7.
go back to reference Stoll C, Alembik Y, Dott B, Roth MP. Epidemiology of congenital eye malformations in 131,760 consecutive births. Ophthal Pediatr Genet. 1992;13:179–86.CrossRef Stoll C, Alembik Y, Dott B, Roth MP. Epidemiology of congenital eye malformations in 131,760 consecutive births. Ophthal Pediatr Genet. 1992;13:179–86.CrossRef
8.
go back to reference Beauchamp GR. Role of the neural crest in anterior segment development and disease. J Pediatr Ophthalmol Strabismus. 1984;21:209–14.PubMed Beauchamp GR. Role of the neural crest in anterior segment development and disease. J Pediatr Ophthalmol Strabismus. 1984;21:209–14.PubMed
9.
go back to reference Michels VV, Hittner HM, Beaudet AL. A clefting syndrome with ocular anterior chamber defect. J Pediatr. 1978;93:444–6.CrossRefPubMed Michels VV, Hittner HM, Beaudet AL. A clefting syndrome with ocular anterior chamber defect. J Pediatr. 1978;93:444–6.CrossRefPubMed
10.
go back to reference Brear DR, Insler MS. Axenfeld’s syndrome associated with systemic abnormalities. Ann Ophthalmol. 1985;17:291–4.PubMed Brear DR, Insler MS. Axenfeld’s syndrome associated with systemic abnormalities. Ann Ophthalmol. 1985;17:291–4.PubMed
11.
go back to reference Frydman M, Weinstock AL, Cohen HA, Savir H, Varsano I. Autosomal recessive Peters anomaly, typical facial appearance, failure to thrive, hydrocephalus, and other anomalies: further delineation of the Krause–Kivlin syndrome. Am J Med Genet. 1991;40:34–40.CrossRefPubMed Frydman M, Weinstock AL, Cohen HA, Savir H, Varsano I. Autosomal recessive Peters anomaly, typical facial appearance, failure to thrive, hydrocephalus, and other anomalies: further delineation of the Krause–Kivlin syndrome. Am J Med Genet. 1991;40:34–40.CrossRefPubMed
12.
go back to reference Traboulsi EI, Maumenee IH. Peters’ anomaly and associated congenital malformations. Arch Ophthalmol. 1992;110:1739–42.PubMed Traboulsi EI, Maumenee IH. Peters’ anomaly and associated congenital malformations. Arch Ophthalmol. 1992;110:1739–42.PubMed
13.
go back to reference Heon E, Barsoum-Homsy M, Cevrette L, Jacob JL, Milot J, Polemeno R, et al. Peters’ anomaly. The spectrum of associated ocular and systemic malformations. Ophthal Pediatr Genet. 1992;13:137–43.CrossRef Heon E, Barsoum-Homsy M, Cevrette L, Jacob JL, Milot J, Polemeno R, et al. Peters’ anomaly. The spectrum of associated ocular and systemic malformations. Ophthal Pediatr Genet. 1992;13:137–43.CrossRef
14.
go back to reference Hennekam RCM, van Svhooneveld MJ, Ardinger HH, van Den Boogaard MJH, Friedburg D, Rudnik-Schoneborn S, et al. The Peters’-plus syndrome: description of 16 patients and review of the literature. Clin Dysmorphol. 1993;2:283–300.PubMed Hennekam RCM, van Svhooneveld MJ, Ardinger HH, van Den Boogaard MJH, Friedburg D, Rudnik-Schoneborn S, et al. The Peters’-plus syndrome: description of 16 patients and review of the literature. Clin Dysmorphol. 1993;2:283–300.PubMed
15.
go back to reference Lesnik Oberstein SA, Kriek M, White SJ, Kalf ME, Szuhai K, den Dunnen JT, et al. Peters plus syndrome is caused by mutation in B3GALTL, a putative glycosyltransferase. Am J Hum Genet. 2006;79:562–6.CrossRefPubMed Lesnik Oberstein SA, Kriek M, White SJ, Kalf ME, Szuhai K, den Dunnen JT, et al. Peters plus syndrome is caused by mutation in B3GALTL, a putative glycosyltransferase. Am J Hum Genet. 2006;79:562–6.CrossRefPubMed
16.
go back to reference Brem AS, Martin D, Callaghan J, Maynard J. Long-term renal risk factors in children with meningomyelocele. J Pediatr. 1987;110:51–5.CrossRefPubMed Brem AS, Martin D, Callaghan J, Maynard J. Long-term renal risk factors in children with meningomyelocele. J Pediatr. 1987;110:51–5.CrossRefPubMed
17.
go back to reference Grünberg J, Verocay MC, Rébori A, Pouso J. Comparison of chronic peritoneal dialysis outcomes in children with and without spina bifida. Pediatr Nephrol. 2007;22:573–7.CrossRefPubMed Grünberg J, Verocay MC, Rébori A, Pouso J. Comparison of chronic peritoneal dialysis outcomes in children with and without spina bifida. Pediatr Nephrol. 2007;22:573–7.CrossRefPubMed
18.
go back to reference Hamdi M, Mohan P, Little DM, Hickey DP. Successful renal transplantation in children with spina bifida: long term single center experience. Pediatr Transplant. 2004;8:167–70.CrossRefPubMed Hamdi M, Mohan P, Little DM, Hickey DP. Successful renal transplantation in children with spina bifida: long term single center experience. Pediatr Transplant. 2004;8:167–70.CrossRefPubMed
Metadata
Title
A girl with Peters plus syndrome associated with myelomeningocele and chronic renal failure
Authors
Osamu Motoyama
Hiroko Arai
Ryoko Harada
Kei Hasegawa
Kikuo Iitaka
Publication date
01-08-2010
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 4/2010
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-010-0283-2

Other articles of this Issue 4/2010

Clinical and Experimental Nephrology 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.